AI assistant
NovoCure Ltd — Director's Dealing 2021
Aug 6, 2021
31949_dirs_2021-08-06_e9a3f69d-f9e1-4372-8053-ed61336e6d92.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2021-08-05
Reporting Person: Madden Martin J. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-05 | Ordinary Shares | S | 34 | $153.13 | Disposed | 384 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Restricted Stock Units | 15620 | Direct |
Footnotes
F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2: Represents shares indirectly beneficially owned by Mr. Madden that are held by his child with whom he shares a residence. Mr. Madden disclaims beneficial ownership of these shares.